-
公开(公告)号:US12234293B2
公开(公告)日:2025-02-25
申请号:US17846950
申请日:2022-06-22
Inventor: Sanjay Khandekar , Patrick Mayes , Joanna Opalinska
IPC: A61K39/395 , A61K31/573 , A61K31/69 , A61K47/68 , A61P35/00 , C07K16/28 , C07K16/30 , C07K19/00 , A61K39/00 , C07K14/71
Abstract: Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and a proteasome inhibitor (e.g. bortezomib). The combinations can also include an anti-inflammatory compound (e.g. dexamethasone).
-
公开(公告)号:USD1053891S1
公开(公告)日:2024-12-10
申请号:US29852639
申请日:2022-09-08
Designer: Kaushal Kishore , Mala Kiran Talekar
-
公开(公告)号:US12122828B2
公开(公告)日:2024-10-22
申请号:US18460944
申请日:2023-09-05
Inventor: Gerben Bouma , Edward Thomas Coulstock , David Dixon , Stephanie Hopley , Alan Peter Lewis , Jessica Lynn Neisen
CPC classification number: C07K16/244 , A61K2039/505 , C07K2317/92 , C07K2317/94
Abstract: Provided herein are interleukin 7 (IL-7) binding proteins, pharmaceutical compositions and their use in the treatment or prevention of a disease or condition.
-
公开(公告)号:US12043436B2
公开(公告)日:2024-07-23
申请号:US17896538
申请日:2022-08-26
Inventor: Francesco Sanmartin
CPC classification number: B65B59/04 , A61L2/04 , B65B3/003 , B65B7/2821 , B65B43/42 , B65B55/025 , A61L2202/21
Abstract: A modular production system including a plurality of production modules connected in a linear series to form a production tunnel, and collectively defining a production channel, and wherein at least one fluid inlet port defined along the production tunnel, said inlet port is in fluid communication with a pressurized fluid source, whereby influx of fluid from said fluid source through said fluid inlet port acts to maintain the fluid pressure within the production channel at a higher pressure than the atmospheric pressure outside of the production tunnel; and wherein one of said production modules positioned between said proximal-most and distal-most production modules comprises a depyrogenator and/or sterilization module, comprising a transparent tubular body, and an irradiation source positioned external to said transparent tubular body, said irradiation source capable of heating the internal environment of the depyrogenation and/or sterilization module to a temperature sufficient to depyrogenate or sterilize articles passing therethrough, and associated processes.
-
公开(公告)号:US20240180933A1
公开(公告)日:2024-06-06
申请号:US18358998
申请日:2023-07-26
Inventor: Andrew B. BENOWITZ , David T. FOSBENNER , Bryan Wayne KING , Stuart Paul ROMERIL
IPC: A61K31/675 , A61K31/44 , A61P35/02 , C07D213/85 , C07F9/58
CPC classification number: A61K31/675 , A61K31/44 , A61P35/02 , C07D213/85 , C07F9/58 , C07B2200/13
Abstract: The invention relates to substituted pyridine derivatives that are inhibitors of the activity of DNA methyltransferase 1 (DNMT1). The invention also relates to pharmaceutical compositions comprising such compounds and methods of using such compounds in the treatment of cancer, pre-cancerous syndromes, beta haemoglobinopathy disorders, and other diseases associated with inappropriate DNMT1 activity.
-
公开(公告)号:US11976113B2
公开(公告)日:2024-05-07
申请号:US16988257
申请日:2020-08-07
Inventor: Steven Grant , Martin Orecchia , Chika Akinseye , Laura Hook , Alan Lewis , Tejinder Bhinder
IPC: C07K16/24 , A61K39/395 , A61K39/00
CPC classification number: C07K16/244 , A61K39/3955 , A61K2039/505 , C07K2317/24 , C07K2317/33 , C07K2317/51 , C07K2317/515 , C07K2317/52 , C07K2317/524 , C07K2317/565 , C07K2317/567 , C07K2317/71 , C07K2317/72 , C07K2317/76 , C07K2317/90 , C07K2317/92 , C07K2317/94
Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
-
公开(公告)号:US11970480B2
公开(公告)日:2024-04-30
申请号:US17663749
申请日:2022-05-17
Inventor: Adam Kenneth Charnley , Michael G. Darcy , Jason W. Dodson , Xiaoyang Dong , Terry V. Hughes , Jianxing Kang , Lara Kathryn Leister , Yiqian Lian , Yue Li , John F. Mehlmann , Neysa Nevins , Joshi M. Ramanjulu , Joseph J. Romano , Gren Z. Wang , Guosen Ye , Daohua Zhang
IPC: C07D403/14 , C07D405/14 , C07D413/14 , C07D487/22 , C07D493/10 , C07D498/18 , C07F9/6558
CPC classification number: C07D403/14 , C07D405/14 , C07D413/14 , C07D487/22 , C07D493/10 , C07D498/18 , C07F9/65583
Abstract: Disclosed are compounds having the formula:
wherein q, r, s, A, B, C, RA1, RA2, RB1, RB2, RC1, RC2, R3, R4, R5, R6, R14, R15, R16, and R17, are as defined herein, or a tautomer thereof, or a salt, particularly a pharmaceutically acceptable salt, thereof.-
公开(公告)号:US11945826B2
公开(公告)日:2024-04-02
申请号:US17429088
申请日:2020-02-11
Inventor: Mark Elban , Michal Pawel Glogowski , Michael Clinton Koetting , Brian Griffin Lawhorn , Jay M. Matthews , Jaclyn Renee Patterson
IPC: C07D498/04 , C07D498/10
CPC classification number: C07D498/04 , C07D498/10 , C07B2200/13
Abstract: The present invention relates hydroxypyridoxazepine compounds, methods of making them, pharmaceutical compositions containing them and their use as Nrf2 activators. In particular, the invention relates to compounds of Formula (I), and pharmaceutically acceptable salts thereof, or a tautomer thereof, or a hydrate thereof.
-
公开(公告)号:US20240051972A1
公开(公告)日:2024-02-15
申请号:US17899877
申请日:2022-08-31
Applicant: GlaxoSmithKline Intellectual Property Development Limited , The University of North Carolina at Chapel Hill , ViiV Healthcare Company
Inventor: Martha DE LA ROSA , Richard M. DUNHAM , David MARGOLIS , Vincent Wing-Fai TAI , Jun TANG
IPC: C07D519/00 , A61P31/18
CPC classification number: C07D519/00 , A61P31/18
Abstract: The invention relates to compounds of Formula (I), (Ia), (Ib), (II) or (III), salts thereof, pharmaceutical compositions thereof, as well as therapeutic methods of treatment and prevention.
-
公开(公告)号:US11795474B2
公开(公告)日:2023-10-24
申请号:US16606281
申请日:2018-04-18
Inventor: Conrad Vink
CPC classification number: C12N15/86 , C07K14/161 , C07K14/162 , C12N2740/13052 , C12N2740/15052 , C12N2740/16052 , C12N2799/027 , C12N2830/003 , C12N2830/006 , C12N2830/60
Abstract: The invention relates to retroviral producer cell comprising nucleic acid sequences encoding: gag and pol proteins; envelope protein or a functional substitute thereof; amplifiable selection marker; and the RNA genome of the retroviral vector particle, wherein said nucleic acid sequences are all integrated at a single locus within the retroviral producer cell genome. The invention also relates to nucleic acid vectors comprising a non-mammalian origin of replication and the ability to hold at least 25 kilobases (kb) of DNA, characterized in that said nucleic acid vector comprises retroviral nucleic acid sequences encoding: gag and pol proteins, and an env protein or a functional substitute thereof. The nucleic acid vector additionally comprises nucleic acid sequences encoding an amplifiable selection marker. The invention also relates to uses and methods using said nucleic acid vector in order to produce stable retroviral packaging and producer cell lines.
-
-
-
-
-
-
-
-
-